Literature DB >> 16475050

Oral anticoagulation control: the European perspective.

David A Fitzmaurice1.   

Abstract

We describe the results of a novel complete care package using point-of-care INR testing and computerized decision support for the management of oral anticoagulation by nurse-led primary care clinics in the United Kingdom. We found such therapy to be as safe and effective as traditional hospital-based care for oral anticoagulation in the UK as determined by adverse events or International Normalized Ratio (INR) time in range. We then review the literature as it pertains to the safety, efficacy, and cost effectiveness of patient self-management with point-of-care INR testing at home and discuss the implications for such care in the UK.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16475050     DOI: 10.1007/s11239-006-5584-7

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  26 in total

1.  Antithrombotic treatment and atrial fibrillation.

Authors:  G D Lowe
Journal:  BMJ       Date:  1992-12-12

2.  A randomised controlled trial of patient self management of oral anticoagulation treatment compared with primary care management.

Authors:  D A Fitzmaurice; E T Murray; K M Gee; T F Allan; F D R Hobbs
Journal:  J Clin Pathol       Date:  2002-11       Impact factor: 3.411

3.  Near patient testing in primary care.

Authors:  R Hobbs
Journal:  BMJ       Date:  1996-02-03

4.  Service provision and use of anticoagulants in atrial fibrillation.

Authors:  C M Sudlow; H Rodgers; R A Kenny; R G Thomson
Journal:  BMJ       Date:  1995-08-26

5.  Anticoagulation in patients with atrial fibrillation. GPs struggle to meet demand.

Authors:  J Shakespeare
Journal:  BMJ       Date:  1994-02-05

6.  Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Italian Study on Complications of Oral Anticoagulant Therapy.

Authors:  G Palareti; N Leali; S Coccheri; M Poggi; C Manotti; A D'Angelo; V Pengo; N Erba; M Moia; N Ciavarella; G Devoto; M Berrettini; S Musolesi
Journal:  Lancet       Date:  1996-08-17       Impact factor: 79.321

7.  Home prothrombin time monitoring after the initiation of warfarin therapy. A randomized, prospective study.

Authors:  R H White; S A McCurdy; H von Marensdorff; D E Woodruff; L Leftgoff
Journal:  Ann Intern Med       Date:  1989-11-01       Impact factor: 25.391

8.  Oral anticoagulation self-management and management by a specialist anticoagulation clinic: a randomised cross-over comparison.

Authors:  M E Cromheecke; M Levi; L P Colly; B J de Mol; M H Prins; B A Hutten; R Mak; K C Keyzers; H R Büller
Journal:  Lancet       Date:  2000-07-08       Impact factor: 79.321

9.  Home monitoring of warfarin therapy in children with a whole blood prothrombin time monitor.

Authors:  P Massicotte; V Marzinotto; P Vegh; M Adams; M Andrew
Journal:  J Pediatr       Date:  1995-09       Impact factor: 4.406

Review 10.  Use of warfarin in non-rheumatic atrial fibrillation: a commentary from general practice.

Authors:  K G Sweeney; D P Gray; R Steele; P Evans
Journal:  Br J Gen Pract       Date:  1995-03       Impact factor: 5.386

View more
  4 in total

1.  Is patient self-testing a good thing?

Authors:  Lynn B Oertel; Edward N Libby
Journal:  J Thromb Thrombolysis       Date:  2010-02       Impact factor: 2.300

2.  [Prevalence of oral anticoagulation and quality of its management in primary healthcare: A study by the Health Sentinel Network of the Region of Valencia (Spain)].

Authors:  Ana Boned-Ombuena; Jordi Pérez-Panadés; Aurora López-Maside; Maite Miralles-Espí; Sandra Guardiola Vilarroig; Desamparados Adam Ruiz; Oscar Zurriaga
Journal:  Aten Primaria       Date:  2017-04-10       Impact factor: 1.137

3.  [Multiple morbidity patterns, level of control and haemorrhagic risk in patients with vitamin K antagonists].

Authors:  David Pérez-Manchón; Gema María Álvarez-García; Montserrat Ruíz-López; Jesús Guodemar-Pérez; Juan Pablo Hervás-Pérez
Journal:  Aten Primaria       Date:  2017-11-11       Impact factor: 1.137

4.  Point-of-Care International Normalized Ratio (INR) Monitoring Devices for Patients on Long-term Oral Anticoagulation Therapy: An Evidence-Based Analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2009-09-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.